Peptyes

Age Verification

This site is restricted to individuals 21 years of age or older. These products are for research use only and are not for human consumption.

By entering you agree to our Terms of Service and confirm you are 21 years of age or older.

CJC-1295 No DAC + Ipamorelin 10mg

Endocrine & Hormonal

CJC-1295 No DAC + Ipamorelin 10mg

Research Use Only

$75.00


Dual-secretagogue blend pairing a GHRH analog with a selective GHS-R1a agonist for GH-axis synergy research.

Research Use Disclaimer

All products are designated Research Use Only (RUO). Not for human or animal consumption. Not a drug, supplement, or food product. Must be handled only by qualified research professionals in a controlled laboratory environment. Purchasers assume full responsibility for compliance with all applicable federal, state, and local regulations. Must be 21 years of age or older to purchase.

Lab Tested
COA Included
Cold-Packed Shipping
Secure Checkout

Overview

This combination unites two compounds that reach growth hormone release from opposite sides of the axis: CJC-1295 (No DAC), a short-acting GHRH analog acting upstream through the GHRH receptor, and Ipamorelin, a highly selective pentapeptide agonist of GHS-R1a. Each pathway converges on somatotroph GH granule release through different intracellular routes, which is the scientific rationale for studying them together in a single pre-formulated blend.

Mechanism of Action

In somatotroph preparations, CJC-1295 (No DAC) activates Gs-coupled cAMP/PKA signaling while Ipamorelin engages Gq/11-mediated phospholipase C, IP3-dependent calcium release, and PKC activation. Applied together, the two cascades produce GH release responses consistent with pharmacological synergy — exceeding the output of either compound alone at equivalent concentrations. Ipamorelin's minimal off-target activity at adrenocortical and lactotroph receptor systems keeps the experimental background clean.

Specifications

  • Purity: ≥99% (HPLC) with mass-spectrometry identity confirmation
  • Form: Lyophilized powder, pre-blended
  • Composition: CJC-1295 (No DAC) + Ipamorelin
  • CAS Numbers: CJC-1295: 446036-97-1 · Ipamorelin: 170851-70-4
  • Molecular Weights: CJC-1295: ~3367.9 g/mol · Ipamorelin: 711.86 g/mol

Research Applications

  • GH-axis synergy and dual-secretagogue protocols
  • GHRHR vs GHS-R1a pathway convergence studies
  • GHS-R1a selectivity profiling
  • Pulsatile GH secretion modeling
  • Secretagogue comparative pharmacology

Lab Reports

Third-party certificates of analysis for this compound.

Ipamorelin_-_10mg_-_2146000

Lot: DPS-2146000Tested: 8/13/2026Lab: Horizon Analytical
View Report (PDF)

Ipamorelin_-_10mg_-_9160996

Lot: DPS-9160996Tested: 9/12/2026Lab: Horizon Analytical
View Report (PDF)

CJC-1295_No_DAC_-_10mg_-_7771773_5442539b-04ed-4a17-aa8b-c75ef2b08282

Lot: DPS-7771773Tested: 8/13/2026Lab: Horizon Analytical
View Report (PDF)

CJC-1295_No_DAC_Ipamorelin_-_10mg_-_9043831

Lot: DPS-9043831Tested: 8/13/2026Lab: Horizon Analytical
View Report (PDF)

You may also like

Research Use Only · Not for human consumption · Must be 21+ to purchase

All products are designated Research Use Only (RUO). Not for human or animal consumption. Not a drug, supplement, or food product. Must be handled only by qualified research professionals in a controlled laboratory environment. Purchasers assume full responsibility for compliance with all applicable federal, state, and local regulations. Must be 21 years of age or older to purchase.

© 2026 Peptyes. All rights reserved.

Questions? Contact us · +1 (645) 225-2897